Prot# 127-014: A Phase 3 Clinical Trial to Assess Perfusion and Obstruction Identified by Non-Invasive Technology Using PB127 Ultrasound Contrast Agent in Patients with Suspected Obstructive Coronary Artery Disease II

Project: Research project

StatusFinished
Effective start/end date12/6/0712/6/08

Funding

  • POINT Biomedical Corporation (127-014)